Immunotherapy Resistance in Kidney Cancer Driven by Myeloid Cell Signaling
October 31, 2025
October 31, 2025
BOSTON, Massachusetts, Oct. 31 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:
* * *
Immunotherapy Resistance in Kidney Cancer Driven by Myeloid Cell Signaling
*
RESEARCH SUMMARY
Study Title: Myeloid cells mediate interferon-driven resistance to immunotherapy in
advanced renal cell carcinoma
Publication: Immunity - October 2025
Corresponding . . .
* * *
Immunotherapy Resistance in Kidney Cancer Driven by Myeloid Cell Signaling
*
RESEARCH SUMMARY
Study Title: Myeloid cells mediate interferon-driven resistance to immunotherapy in
advanced renal cell carcinoma
Publication: Immunity - October 2025
Corresponding . . .
